TOPDDRIVE Trademark
TOPDDRIVE is a USPTO trademark filed by Callio Operating Co, Inc.. Status: Pending.
Trademark Facts
| Mark | TOPDDRIVE |
|---|---|
| Serial Number | 99442152 |
| Status | Pending |
| Filing Date | 2025-10-14 |
| Mark Type | Word |
| Nice Classes | 005 (Pharmaceuticals), 040 (Material Treatment), 042 (Software & IT) |
| Owner | Callio Operating Co, Inc. |
| Attorney of Record | Joyce Liou |
| Prosecution Events | 14 |
| Latest Event | NPUB on 2026-05-05 |
Goods & Services
Class 005: Pharmaceutical and biological preparations for the treatment of cancer; Pharmaceuticals and biological preparations for prophylactic, diagnostic, and therapeutic use in treating, preventing, and managing cancer; Therapeutic agents for medical use, namely, proteins and derivatives, antibody-drug conjugates, immunostimulatory antibody-drug conjugates, antibodies with multiple drug or cytokine conjugates, multispecific antibodies, and engineered antibodies; Pharmaceutical and biological preparations for the prevention, diagnosis and treatment of diseases for scientific, clinical, medicinal, therapeutic and diagnostic purposes; Pharmaceutical and biological preparations for use in oncology; Class 040: Custom manufacturing of pharmaceuticals and therapeutic agents for medical use; Class 042: Research and development in the fields of pharmaceuticals, biologics, chemistry, protein engineering, proteins and derivatives, antibody-drug conjugates, immunostimulatory antibody-drug conjugates, antibodies with multiple drug or cytokine conjugates, multispecific antibodies, and engineered antibodies, oncology; Providing medical scientific research information in the fields of pharmaceuticals, biologics, chemistry, protein engineering, proteins and derivatives, antibody-drug conjugates, immunostimulatory anti-drug conjugates, antibodies with multiple drug or cytokine conjugates, multispecific antibodies, and engineered antibodies, oncology, and immunology; Drug discovery, custom design, and development services featuring therapeutic agents for the treatment and prevention of diseases; Scientific investigations for medical purposes featuring clinical trials
Recent Prosecution Activity
| Date | Document | Type |
|---|---|---|
| 2026-04-07 | Response to Office Action | ROA |
| 2026-03-20 | Notice of Non-Final Office Action | NFO |
| 2026-03-20 | Non-Final Action | NFIN |
| 2026-03-12 | XSearch Search Summary | XSS |
| 2025-10-14 | Application | APP |
USPTO Refusals on Record
- indefinite_identification